NTU Singapore is working with China's Southern University of Science and Technology (SUSTech) and Swedish biotechnology ...

A tiny antibody component could fundamentally transform the treatment of cystic fibrosis: For the first time, researchers ...

A new inhaled therapy targeting lung inflammation shows promise in reducing damage and improving recovery after severe ...

Avalyn Pharma is led by CEO Lyn Baranowski, who previously worked at Pearl Therapeutics, where she helped develop treatments ...

University of Colorado Denver Biomedical Engineering Associate Professor Chelsea Magin is developing a lung model to help ...

A tiny antibody component could fundamentally transform the treatment of cystic fibrosis: For the first time, researchers ...

A new inhaled therapy targets ANGPTL4 to reduce lung inflammation, fluid buildup, and scarring after infections. Preclinical ...

Nanyang Technological University, Singapore (NTU Singapore) is working with China's Southern University of Science and Technology (SUSTech) and Swedish biotechnology company Lipigon Pharmaceuticals AB ...

Inside the deadly disease confounding medicine, researchers piecing together clues and the breakthrough that meant survival ...

This press release shall not constitute an offer to sell, or a solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which ...

Isolated antineutrophil cytoplasmic antibody-associated interstitial lung disease is an increasingly recognized fibrotic ILD phenotype.

Her treatment is complicated by high costs and insurance limits, affecting consistent access to care, medication, and ...